恶性外周神经鞘瘤组织学变异型中H3K27me3表达与甲基化状态
研究探讨MPNST各组织学变异型中H3K27me3表达丢失及DNA甲基化谱。全基因组倍增见于68%、SSTR2扩增见于32%的MPNST;H3K27me3丢失总体38%,经典组织学76%,异源性成分23%,仅形态无法诊断者14%。DNA甲基化谱区分MPNST与模仿病变,形成MeGroup 4和5两簇。
要点
- 经典MPNST中H3K27me3丢失率76%,异源性成分者仅23%。
- 全基因组倍增见于68%、SSTR2扩增见于32%的MPNST。
- DNA甲基化分MeGroup 4和5,MeGroup 4多为经典且H3K27me3丢失。
核心结论
- MPNST中H3K27me3表达丢失总体为38%,经典组织学病例达76%,异源性成分病例仅23%。
- DNA甲基化谱可区分MPNST与组织学模仿病变,且与解剖部位无关,形成MeGroup 4和5两簇。
- MeGroup 4多为经典MPNST且H3K27me3丢失,MeGroup 5为非经典组织学且表达H3K27me3并与未分化肉瘤聚类。
研究设计与样本
- 研究纳入MPNST病例,采用分子病理方法重新分类模仿病变并分析H3K27me3表达与DNA甲基化谱。
主要发现
- 全基因组倍增见于68%的MPNST,SSTR2扩增见于32%的MPNST。
- H3K27me3丢失总体38%,经典组织学76%,异源性成分23%,仅形态无法诊断者14%。
- H3K27me3丢失在其他高级别肉瘤中罕见,且与MPNST inferior outcome无关。
- MeGroup 4与5由PRC2相关基因差异甲基化区分,MeGroup 4多数基因启动子区高甲基化。
- MeGroup 4和5中H3K27me3保留的MPNST其甲基化谱与PRC2核心组分突变无关。
关键数值与推荐
- H3K27me3表达丢失总体38%,经典组织学76%,异源性成分23%,仅形态无法诊断者14%。
临床怎么用
- 分子病理进展有助于自信分类MPNST模仿病变,应结合H3K27me3免疫组化与DNA甲基化谱辅助诊断。
- H3K27me3丢失对经典MPNST支持价值高,但对异源性成分或形态诊断困难病例敏感性低。
局限性
- MeGroup 4和5中H3K27me3保留病例的驱动因素尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnosing MPNST can be challenging, but genetic alterations recently identified in polycomb repressive complex 2 (PRC2) core component genes, EED and SUZ12, resulting in global loss of the histone 3 lysine 27 trimethylation (H3K27me3) epigenetic mark, represent drivers of malignancy and a valuable diagnostic tool. However, the reported loss of H3K27me3 expression ranges from 35% to 84%. We show that advances in molecular pathology now allow many MPNST mimics to be classified confidently. We confirm that MPNSTs harbouring mutations in PRC2 core components are associated with loss of H3K27me3 expression; whole-genome doubling was detected in 68%, and SSTR2 was amplified in 32% of MPNSTs. We demonstrate that loss of H3K27me3 expression occurs overall in 38% of MPNSTs, but is lost in 76% of histologically classical cases, whereas loss was detected in only 23% cases with heterologous elements and 14% where the diagnosis could not be provided on morphology alone. H3K27me3 loss is rarely seen in other high-grade sarcomas and was not found to be associated with an inferior outcome in MPNST. We show that DNA methylation profiling distinguishes MPNST from its histological mimics, was unrelated to anatomical site, and formed two main clusters, MeGroups 4 and 5. MeGroup 4 represents classical MPNSTs lacking H3K27me3 expression in the majority of cases, whereas MeGroup 5 comprises MPNSTs exhibiting non-classical histology and expressing H3K27me3 and cluster with undifferentiated sarcomas. The two MeGroups are distinguished by differentially methylated PRC2-associated genes, the majority of which are hypermethylated in the promoter regions in MeGroup 4, indicating that the PRC2 target genes are not expressed in these tumours. The methylation profiles of MPNSTs with retention of H3K27me3 in MeGroups 4 and 5 are independent of mutations in PRC2 core components and the driver(s) in these groups remain to be identified. Our results open new avenues of investigation. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Lyskjaer I, Lindsay D, Tirabosco R, et al. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours. J Pathol. 2020. PMID: 32666581. doi:10.1002/path.5507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。